Modern medicine is changing not only how long people live, but also which diseases they are most likely to experience as they grow older.
A major study from researchers at the Max Planck Institute for Demographic Research (MPIDR) and Karolinska Institute in Sweden shows that progress has taken very different forms depending on the disease.
For some serious conditions, prevention has become so effective that fewer people are developing them in the first place. For cancer, however, more people are being diagnosed while survival has improved. These different trends are changing the health needs of older populations.
The researchers studied heart attacks, strokes, hip fractures, and malignant cancers. These conditions are especially important in older age because they can lead to disability, long hospital stays, loss of independence, or death.
Understanding how often they occur and how long people survive afterward can help health systems prepare for the future.
The team used Sweden’s extensive national health registry data. They examined generations born between 1904 and 1960 and followed health records covering the years 1987 through 2022. Their analysis focused on adults between ages 60 and 90.
The researchers measured several things. They calculated how often people of particular ages were newly diagnosed with each disease and examined the percentage who survived for one year and five years after diagnosis. They also studied how common each condition was among people at ages 70, 80, and 90.
This distinction is important because the number of people living with a disease depends on two forces. One is how many people develop the disease, while the other is how long people survive after developing it. Better medicine can therefore change the population in very different ways.
Heart attacks provide a striking example. In earlier generations, a major heart attack was far more likely to lead to death, partly because effective emergency treatments and preventive medicines were limited. Today, treatment can include rapid reopening of blocked arteries, medicines to prevent blood clots, cholesterol-lowering drugs, and better control of high blood pressure.
Prevention has improved as well. Greater awareness of smoking, blood pressure, cholesterol, diet, and physical activity has helped reduce cardiovascular risk in many populations. The Swedish data suggest that these preventive gains have been especially important.
Among 75-year-old women, for example, the rate of new heart attacks fell by about half when researchers compared women born in 1920 with those born in 1940. At the same time, one-year survival after a heart attack rose from 51% to 75%. This means fewer women were having heart attacks and a much larger share of those who did survived the following year.
Similar broad patterns were found for strokes and hip fractures. The decline in new cases was stronger than the improvement in survival after the event. As a result, the proportion of older people living with a history of these conditions declined.
Hip fractures are particularly important in aging populations because they can seriously reduce mobility and independence. Improvements in fall prevention, osteoporosis care, general health, and other areas may help explain why fewer severe events are occurring. Stroke prevention has also benefited from better blood pressure treatment and management of conditions such as atrial fibrillation.
Cancer followed a different path. Instead of seeing a large decline in new diagnoses, researchers found that cancer was becoming more common in the populations they studied. At the same time, people diagnosed with cancer were increasingly likely to survive.
For men between ages 80 and 89, the difference was clear. About 17.3% of men born in 1912 were diagnosed with cancer during that decade of life, compared with 20.7% of men born in 1931. That represents an increase of roughly one-fifth.
There are several possible reasons why more cancer is being detected. People are living longer, screening and medical imaging can identify cancers that might previously have gone unnoticed, and diagnostic methods have become more sensitive. Changes in exposure to cancer risk factors may also affect the number of cases.
At the same time, cancer treatment has improved enormously. Surgery has become safer and more precise, radiation treatment has advanced, and newer medicines can target particular features of cancer cells or help the immune system attack tumors. Earlier diagnosis can also give patients a better chance of successful treatment.
The researchers describe the balance between new cases and survival as an ‘incidence-survival gap.’ In simple terms, it shows whether medical progress is mainly preventing a disease from happening or helping people live longer after it occurs. The balance can strongly affect how common a disease becomes in an aging population.
The study was published in The Lancet Regional Health – Europe. Anna-Kathleen Piereth, a researcher and Ph.D. student at MPIDR and Karolinska Institute, said the findings suggest that medical progress has been strongest in preventing heart attacks, strokes, and hip fractures, while progress against cancer has been especially strong in diagnosis and treatment after disease develops.
The findings also have important implications for health services. If more people survive cancer for many years, health systems will need to provide long-term follow-up, monitor treatment effects, and help patients manage cancer alongside other conditions. Older adults may increasingly live with several health problems at once rather than experience one isolated illness.
There are important limits to the study. Sweden has a high-income health system, extensive medical records, and relatively low mortality, so the exact trends may differ in countries with different health systems, lifestyles, or access to care. The research also describes population patterns and cannot by itself prove which individual medical advances caused each change.
Even so, the long observation period and detailed national registry information are major strengths. The results show that medical progress cannot be measured only by whether people survive a disease. Preventing disease, detecting it earlier, extending survival, and managing long-term illness can each reshape a population in different ways.
Overall, the study paints an encouraging but complicated picture. Older people in Sweden are increasingly avoiding some devastating events such as heart attacks and strokes, yet more are living with cancer after diagnosis. Success in medicine therefore creates new challenges, making coordinated and long-term care increasingly important as populations continue to age.
If you care about heart health, please read studies that yogurt may help lower the death risks in heart disease, and coconut sugar could help reduce artery stiffness.
For more information about health, please see recent studies that Vitamin D deficiency can increase heart disease risk, and results showing vitamin B6 linked to lower death risk in heart disease.
